Study of Efficacy and Safety of Eltrombopag in Patients With Poor Graft Function
Clinical trial NCT03718533 · TERMINATED
Trial details
- NCT number
- NCT03718533
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-17
- Primary completion
- 2020-11-03
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.